Surprised to hear about Towana Looney, a patient in a clinical trial, whose gene-edited pig kidney functioned for 130 days! That's the longest on record. This progress in xenotransplantation offers new hope for tackling the critical shortage of donor organs.

Thinking about how much earlier diagnosis could change things. Mount Sinai found RNA biomarkers in 'SECmeres' (tiny blood particles) that show clearer Alzheimer's signals than other tests. Imagine detecting it before major symptoms. That's a step toward better treatments.

The first human trial using cellular reprogramming to rejuvenate damaged cells has begun. They're trying 3 specific genetic "switches" (Yamanaka factors) on one patient's eye. It's like finding a precise 3-digit code to turn back the clock on cells. Quietly hopeful.

A pilot study of 58 older adults (60+) found specific probiotics (6B CFU L. helveticus & B. longum for 12 weeks) modestly reduced depression symptoms. It shows how the gut-brain axis might offer new avenues for mental health support.

gonorrhoea is becoming untreatable with current antibiotics. doctors are running out of options. but AI just screened 6M chemicals and found two new candidates, even clearing infections in lab models. this targets a fresh bacterial weakness, offering a real path forward.

new research suggests fats aren't all the same for type 2 diabetes. palmitic acid, a common saturated fat, may fuel insulin resistance. but oleic acid, from olive oil, seems to help protect your cells.

a new model predicting abdominal compartment syndrome (pressure build-up in the belly) risk for diabetic patients after hernia surgery is impressive. factoring in nutrition, blood sugar, and inflammation, it predicted 72.7% vs 1.0%.

Twin studies continue to reveal so much about us. New research on hoarding symptoms found 2.3% of twins met the clinical threshold, with 4.1% of males vs 2.1% of females. It really highlights how complex our behaviors are, and how genetics play a role.

this is surprising! Greenstone and Intel are using AI to find new meds. they're leveraging the world's largest collection of human iPSCs – these are cells that can become any cell in the body – to improve drug safety and tailor treatments to people.

A Phase 1 trial for cellular reprogramming is underway: 18 people are getting gene therapy in their eyes to essentially reset the biological age of damaged cells. Using specific 'Yamanaka factors' to restore optic nerve function. This quiet, fundamental progress is what matters.

Free Speaking English Test app.speakfloe.com#/onboarding/...

Researchers used AI to find 1,179 new antibiotic candidates ('prionins') within proteins called prions, known for causing brain diseases. Screening 19.3M fragments, this points to a surprising role for prions in immunity and a new path for drugs.

new research shows our different cell types age independently, not uniformly. finding that accelerated lung cell aging increased lung cancer risk by 58% really highlights how this impacts disease.

scientists just wrapped a phase 3 trial where in vivo crispr (gene editing directly inside the body!) cut hereditary angioedema attacks by 87%. 62% of patients were attack-free for 6 months. this means a major improvement for people with this rare inherited disease.

new data on daraxonrasib for metastatic pancreatic cancer: it doubled survival and almost halved serious side effects. for a cancer usually so aggressive, how much does quality of life improve when treatment is both more effective and less brutal?

childhood trauma has deep biological impacts. ucla found it changes how your cells' mitochondria (their energy makers) produce fuel. in 143 adults, early adversity linked to blood cells making energy differently—a mechanism tied to lifelong health issues.

The FDA approved Utebzi, the first oral carbapenem antibiotic, for complicated UTIs. This means powerful treatment (58.5% success in PIVOT-PO trial with 1,690 patients) can now happen outside the hospital for many, offering a vital new option.

For years, we largely assumed common food preservatives were safe. But a study of 112,000 people found those eating the most non-antioxidant ones had a 29% higher risk of high blood pressure and 16% higher risk of heart disease. Changes how we see 'safe' ingredients.

A new combination therapy for relapsed multiple myeloma reduced the risk of progression or death by up to 72%! This blood cancer is so challenging, so seeing 81.3% of patients progression-free at 2 years (vs. 51.2% standard care) from a Phase 3 trial is truly hopeful.

It’s heartening to see new approaches in cancer care. Mirvetuximab soravtansine, targeting ovarian cancer cells directly, offers a crucial new option after decades. Trial patients lived 16.5 months (vs 12.8 with chemo), with over 30% seeing tumor shrinkage.

FDA approved Utebzi, the first oral carbapenem (powerful antibiotic) for complicated UTIs. Previously IV, it showed 58.5% success vs. 60.2% for IV standard in a 1,690-patient trial. How might this shift serious infection treatment from hospitals to outpatient care?

IBD research I'm watching: A key cause in 3.5% of patients is specific autoantibodies that neutralize IL-10, an immune-regulating protein. This finally helps explain a genetic link. Crucial for understanding patient options.

In preclinical models for ovarian cancer, an engineered stem cell therapy eliminated tumors and achieved 100% long-term survival when combined with another treatment. Human trials are planned for late 2026.

I'm surprised by these HAE trial results. For patients, a single CRISPR gene therapy dose targeting a liver gene reduced hereditary angioedema attacks by 87% in a Phase 3 trial (80 patients). 62% were attack-free for months. Real progress.

Interesting data from a Phase 3 trial on Hereditary Angioedema, a condition causing severe swelling. A single CRISPR gene editing infusion reduced attacks by 87%. 62% of 80 treated patients became attack-free. Looks promising for a long-term solution.

Wow, these Phase 2 results for EDG-7500 in HCM (a thickened heart muscle condition) really caught my eye. 90% of obstructive HCM patients improved. Crucially, it didn't lower LVEF (the heart's pumping ability), a common safety issue with other treatments.

Free English Speaking Test app.speakfloe.com#/onboarding/...

UCLA found a drug, AD-NP1, helped damaged kidney tissue repair in mice by blocking a protein (ENPP1) that hinders healing. Since AD-NP1 is already in Phase 1 human trials for heart repair, this kidney discovery is incredibly promising.

Such hopeful news! The first participant in a trial for Huntington's Disease has received a neural stem cell treatment. Researchers are transplanting immature brain cells to try and repair damaged circuits. It's incredible to see these potential new ways to support brain health.

Most CAR T-cell patients relapse in 5 years. That's tough. New data shows those cancer-fighting cells can accidentally attack *themselves*. But blocking a protein, cathepsin B, stopped this self-sabotage in models, boosting their tumor-killing power.

found a fascinating study today: eating more ultra-processed foods really does lower your ability to focus. 2,192 adults showed a clear drop in attention for every 10% increase, even when eating a healthy mediterranean diet.

We often aim for completely sugar-free. But a mouse study found a sucrose-free, low-fat diet led to impaired glucose control (poor blood sugar regulation) & fatty liver—without weight changes. Does this complicate our "sugar is evil" mindset?

For people impacted by schizophrenia, new research offers a clearer path to better treatments. A study found patients had 13-19% fewer M1 receptors – specific brain cell communication points – in their brains. This is a direct biological clue we've been needing for new therapies.

We're learning IBD isn't just one thing. A study found 3.5% of patients (15k-20k in UK) make antibodies against IL-10, a protein that normally helps control inflammation. This discovery points to personalized treatments for this specific group.

A new *Stem Cell Reports* study shows NewcelX's AstroRx therapy, using stem cells, helps repair myelin in lab/animal models. It clears debris & encourages new oligodendrocytes (myelin-producing cells).

I'm genuinely surprised by this Phase 2 FOP data. Zilurgisertib, for Fibrodysplasia Ossificans Progressiva (bone growing in soft tissues), showed a 99.9% reduction in new abnormal bone formation. That's an incredible result, nearly stopping it.

for ~1 in 4 guys with metastatic prostate cancer, treatment wasn't tailored to their pten genetic flaw. but now, fda approved a drug combo that finally targets that specific mutation. that's a really important step from a phase 3 trial.

New single-dose vaccines for Andes hantavirus showed 100% protection in animal tests. This virus spreads between people & is deadly. Researchers are fast-tracking these to be an emergency tool for exposed individuals during outbreaks.

A real-world study of 201 women found fezolinetant, a non-hormonal treatment, significantly improved menopausal hot flashes, night sweats, anxiety, and depression in as little as 4 weeks. This is promising news for the 80% of women who experience challenging menopausal symptoms.

FDA approved a new KEYTRUDA + WELIREG combo for kidney cancer after surgery, for those at high risk of recurrence. For every 100 patients, this treatment reduced the risk of cancer returning, spreading, or death by 28% compared to KEYTRUDA alone.

scientists just found that combining KEYTRUDA and WELIREG after surgery cuts the risk of clear cell kidney cancer (ccRCC) returning or spreading by 28%. these are new types of drugs, an immune checkpoint blocker and a growth pathway inhibitor.

Princeton AI sees drugs changing cell structures, even a new "flower" shape in the nucleolus (a tiny cellular component). By spotting these internal shifts, we're gaining deep insights. How will this new view of cell biology transform drug discovery for diseases like Alzheimer's?

The FDA approved Tzield for stage 3 Type 1 Diabetes. It significantly slowed the decrease in C-peptide levels (a marker of the body's own insulin production) by 0.13 pmol/mL. This means preserving some natural insulin function, which can make a real difference in managing the ...

🎙️ Take a Free AI-Powered English Speaking Test app.speakfloe.com#/onboarding/...

Repeated antibiotics in early childhood are significantly linked to a higher risk of IBD later. Data shows a 59% increased risk for Crohn's disease and 23% for ulcerative colitis. This matters.

This UCLA study brings hopeful news for early cancer risk assessment. Tracking 6000+ adults for 18 yrs, it links subtle heart changes (like increased heart muscle mass) to future cancers like breast cancer. It could mean earlier insights for patients.

A new liver perfusion technology in SA can better preserve donor livers, meaning more viable organs for transplant. This is a quiet but crucial step for the 4,000+ patients on the waiting list.

New research shows the common joint supplement glucosamine may accelerate Alzheimer's progression. People with mild cognitive impairment taking it were 25% more likely to develop dementia, and diagnosed Alzheimer's patients faced a 25% higher death risk.

New study shows IV statins during a heart attack reduce heart muscle damage significantly. Infarct size (area of tissue death) dropped 20%, edema (swelling due to inflammation) 13% vs oral. It's amazing how precise treatments can better protect the heart.

New Alzheimer's research out of ETH Zurich highlights GRK2 as a previously underappreciated driver of neurodegeneration. In mouse studies, an experimental compound, 'Compound 10,' successfully interrupted this process, reducing nerve cell loss.